Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Peripheral Artery Disease Clinical Trials

100 recruiting trials for Peripheral Artery Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
3
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT03203239

Red Light Treatment in Peripheral Artery Disease

Subjects with a known diagnosis of peripheral artery disease as measured by an abnormal ankle brachial index (\<.9 or \>1.1) will undergo a single 5 min exposure of 670 nm light,...

Sponsor: University of Alabama at BirminghamEnrolling: 401 location
RECRUITINGNCT06253312

Treatment of TASC C and D Aortoiliac Lesions

Background: The treatment of patients with complex aortoiliac disease (AID), classified as Trans-Atlantic Inter-Society consensus II (TASC) class C and D, presents a dilemma for...

Sponsor: Clinical Centre of SerbiaEnrolling: 9001 location
RECRUITINGNCT06829134

Clinical Analysis of the Antihypertensive Effect of Laparoscopic Peripheral Nerve Blockade of the Renal Artery in...

The primary objective of this study is to evaluate the efficacy and safety of laparoscopic renal artery nerve blockade surgery in patients with retroperitoneal diseases...

Sponsor: Ruijin HospitalEnrolling: 2461 location
RECRUITINGNCT05078814

The Prevalence Survey of ALDH Gene Family in Patients With Peripheral Arterial Occlusive Disease or Acute Coronary...

Aldehyde dehydrogenase 2 (ALDH2) is an important enzyme protecting human from the accumulation of aldehyde, the main metabolites of alcohol. The deficiency of ALDH2 gene results...

Sponsor: Chimei Medical CenterEnrolling: 6001 location
RECRUITINGPhase 2NCT06399809

Fisetin to Reduce Senescence and Mobility Impairment in PAD

The investigators propose a pilot randomized trial to gather preliminary data to test the hypothesis that Fisetin will reduce abundance of senescent cells in blood, skeletal...

Sponsor: Northwestern UniversityEnrolling: 341 location
RECRUITINGNCT04511247

SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease

This study aims to conduct a randomized, double blind, randomised controlled multicentre trial of sirolimus drug coated balloon versus standard percutaneous transluminal...

Sponsor: Concept Medical Inc.Enrolling: 21920 locations
RECRUITINGNCT06274697

Validation of a Magnetic Sensor in Arterial Flow Recording, Compared With the Reference Method, at Various Peripheral...

The measurement of magnetic fields emitted by cardiac activity has already been studied in magneto-cardiography. To date, however, this technology has never been evaluated in the...

Sponsor: University Hospital, MontpellierEnrolling: 701 location
RECRUITINGNCT04889105

Exercise Therapy for PAD Using Mobile Health

Peripheral artery disease (PAD) is a highly prevalent condition affecting up to 10% of Veterans that leads to loss of walking ability and increased risk of amputation. Veterans...

Sponsor: VA Office of Research and DevelopmentEnrolling: 751 location
RECRUITINGNCT07374601

The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease

Peripheral artery disease (PAD) is a chronic atherosclerotic disorder characterized by stenosis or occlusion of the extracranial arteries distal to the aortic arch, most commonly...

Sponsor: Peking University First HospitalEnrolling: 3001 location
RECRUITINGNCT06165016

Far Red Light to Improve Functioning in PAD

The LIGHT PAD Trial is a Phase II multi-centered randomized clinical trial to collect preliminary data to test whether daily far red light treatment of the lower extremities in...

Sponsor: Northwestern UniversityEnrolling: 322 locations
RECRUITINGNCT06066268

miRNAs in Critical Limb Ischemia (miRNACLI)

For the present study, 40 patients affected by critical limb ischemia of different severity will be enrolled: patients affected by critical limb ischemia undergoing subgenual...

Sponsor: IRCCS Policlinico S. DonatoEnrolling: 801 location
RECRUITINGNCT05884840

New Cardiovascular Risk Screening Strategy.

Mortality due to cardiovascular disease (CVD) in Spain accounted for 29% of all deaths (32% in women and 26% in men) in 2017. Out of those, 67% were related to a coronary or a...

Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i GurinaEnrolling: 540001 location
RECRUITINGNCT04511234

Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease

This study aims to conduct a randomized, double blind, randomised controlled multicentre trial of sirolimus drug coated balloon versus standard percutaneous transluminal...

Sponsor: Concept Medical Inc.Enrolling: 27920 locations
RECRUITINGNCT06009276

Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status

The purpose of the study is to determine associations between fitness status, bacteria in the mouth, and the blood flow to muscle. This study is trying to find out if fitness...

Sponsor: University of VirginiaEnrolling: 701 location
RECRUITINGNCT07068789

Revascularization of Single Vesrus Multiple Infrapopliteal Vessels in Chronic Limb Threatening Ischemia

This interventional prospective study aims to assess the effectiveness of single vessel versus multiple vessel infrapopliteal angioplasty in patients with chronic threatening limb...

Sponsor: Sohag UniversityEnrolling: 401 location
RECRUITINGPhase 3NCT06059144

Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine

PRESSURE is a multicenter, prospective, randomized, open, blinded end-point assessed (PROBE) trial, that aims to evaluate the efficacy and safety of drug-induced hypertension...

Sponsor: University Hospital, BordeauxEnrolling: 3581 location
RECRUITINGNCT07350499

Aspiration Thrombectomy Using the Symphony or Prodigy System

The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovascular procedures...

Sponsor: Imperative Care, Inc.Enrolling: 7501 location
RECRUITINGNCT05192707

Transcutaneous Oxygen Pressure (TcPO2) Determination.

Upper limb arterial disease is a rare condition compared to lower limb arterial disease. In the lower limb, chronic limb ischemia (CLI) is characterized by an intractable pain or...

Sponsor: Hospices Civils de LyonEnrolling: 601 location
RECRUITINGNCT06033924

Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease

Walking is beneficial for adults with peripheral arterial disease. Benefits include the ability to walk for longer periods and general well being (quality of life). This study...

Sponsor: VA Office of Research and DevelopmentEnrolling: 2253 locations
RECRUITINGPhase 4NCT02842424

Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis

Peripheral artery disease (PAD) is a manifestation of atherosclerosis that produces progressive narrowing and occlusion of the arteries supplying the lower extremities. The most...

Sponsor: University of NebraskaEnrolling: 701 location
RECRUITINGNCT05612945

High-intensity Intervals Versus Low-to-moderate-intensity Exercise Training in Patients With PAD

Supervised exercise training (SET) is considered among first-line therapies for patients with symptomatic lower extremity peripheral artery disease (PAD), combined with general...

Sponsor: Centre Hospitalier Universitaire VaudoisEnrolling: 601 location
RECRUITINGNCT01524276

Product Surveillance Registry

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is...

Sponsor: MedtronicEnrolling: 10000020 locations
RECRUITINGNCT03995238

Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb Amputation

The population of older Veterans with non-traumatic lower limb amputation is growing. Following lower limb amputation, asymmetrical movements persist during walking and likely...

Sponsor: VA Office of Research and DevelopmentEnrolling: 542 locations
RECRUITINGPhase 2NCT07352800

Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic...

The goal of this study is to learn if a new medicine (called antiplatelet and anticoagulant \[APAC\]) can help the body to prevent blood clots and whether APAC is safe and well...

Sponsor: Aplagon OyEnrolling: 423 locations
RECRUITINGNCT04885985

ACOART BTK RENEW:A Post Market Clinical Study

The objective of this prospective, multi-center, single arm study is to obtain further data on the safety and performance of the Acotec Litos\&Tulip Drug-coated Balloon catheters...

Sponsor: Acotec Scientific Co., LtdEnrolling: 1071 location
RECRUITINGNCT05216666

The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty

Residual limping after total hip arthroplasty is empirically associated with the use of lateral approach but has been reported in litterature even with the use of posterior...

Sponsor: Sahlgrenska University HospitalEnrolling: 5801 location
RECRUITINGNCT04252950

Community-based Exercise Following Revascularization for PAD

The primary goal of this clinical trial is to evaluate whether a community-based structured exercise therapy (CB-SET) intervention, which could be accessible and easily...

Sponsor: University of MinnesotaEnrolling: 301 location
RECRUITINGPhase 2 / Phase 3NCT05485961

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a dose-finding study for CSL300 vs...

Sponsor: CSL BehringEnrolling: 231020 locations
RECRUITINGNCT05159856

Early Detection of Long-term Diabetic Complications in Children and Adolescents With Type 1 Diabetes

Aims: To investigate early markers of long-term diabetic complications and the association to an extended glucose metabolic profile comprising glucose control (current and past),...

Sponsor: Steno Diabetes Center CopenhagenEnrolling: 4001 location
RECRUITINGNCT06124586

Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

The planned study is a Randomized Controlled Monocentric Trial, which will provide evidence on whether early angiography in percutaneous transluminal angioplasty (PTA) readiness...

Sponsor: Heinrich-Heine University, DuesseldorfEnrolling: 2001 location
RECRUITINGNCT04027244

Leg Ischaemia Management Collaboration

Single-centre prospective cohort study of patients presenting with severe limb ischaemia (SLI). The primary outcome measure will be 12 month major amputation rate. A historical...

Sponsor: University of LeicesterEnrolling: 4201 location
RECRUITINGNCT07016698

Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)

The XTRACT Registry is a prospective, single arm multicenter study on the use of on the Rotarex(TM) Rotational Excisional Atherectomy System.

Sponsor: C. R. BardEnrolling: 6002 locations
RECRUITINGNCT07157475

Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors

The study is observational and involves patients (pts) with peripheral arterial occlusive disease (PAD) who have undergone lower limb revascularization procedures. Patients who...

Sponsor: Wroclaw Medical UniversityEnrolling: 3001 location
RECRUITINGNCT06832631

VITUS Post-Market Registry

To collect post marketing surveillance data on consecutive patients with peripheral arterial occlusive disease (PAOD) intended to be or treated by the VITUS peripheral drug-coated...

Sponsor: OrbusNeichEnrolling: 28413 locations
RECRUITINGNCT06887101

Impact of Stress on Cardiovascular Events in Patients with Peripheral Arterial Disease

Atherosclerotic cardiovascular disease is the leading cause of morbidity and mortality worldwide. Patients with peripheral arterial disease are at increased risk suffering from...

Sponsor: University Hospital, EssenEnrolling: 3001 location
RECRUITINGNCT07330635

Chronic Wounds and Blood Circulation Detection

Lower limb circulatory insufficiency and the associated chronic wounds are common health problems among the elderly. These issues not only affect the individual's mobility and...

Sponsor: National Health Research Institutes, TaiwanEnrolling: 4251 location
RECRUITINGPhase 4NCT06873321

VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

Venous thromboembolism (VTE) has a high prevalence in patients with multiple comorbidities undergoing complex surgical procedures. Sometimes, extended prophylaxis for VTE with...

Sponsor: Science Valley Research InstituteEnrolling: 1001 location
RECRUITINGPhase 2NCT06482892

TP03HN106 in Patients With Critical Limb Ischemia

Critical limb ischemia (CLI) is the most severe ischemic stage in peripheral arterial disease (PAD) of the lower limbs, characterized by decreased walking ability, resting pain...

Sponsor: Talengen Institute of Life Sciences, Shenzhen, P.R. China.Enrolling: 151 location
RECRUITINGNCT07006467

Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen...

This is the First-In-Human feasibility study of the RFS for below the knee lesions in subjects who experience critical limb ischemia due to the peripheral artery disease. The aim...

Sponsor: StentitEnrolling: 101 location
RECRUITINGNCT04903912

Campania Registry On Peripheral Artery Disease

The CAmpania REgistry on Peripheral Artery Disease (CARE-PAD) is a single-center observational study which has the purpose to collect clinical, laboratory, instrumental,...

Sponsor: Federico II UniversityEnrolling: 10001 location
RECRUITINGNCT06782100

MRI Guided Management of Occlusive Peripheral Arterial Disease

The goal of this observational study is to identify which plaque lesions in patients with peripheral arterial disease are impenetrable and to determine which devices minimize...

Sponsor: The Methodist Hospital Research InstituteEnrolling: 1751 location
RECRUITINGNCT06275113

BRING-UP Prevention

The aim of this observational study is to assess in patients with a documented athero-thrombotic event: coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral...

Sponsor: Heart Care FoundationEnrolling: 600020 locations
RECRUITINGNCT07233798

Presence of Dural Pulsation in Patients Diagnosed With Lumbar Spinal Stenosis

Lumbar spinal stenosis is defined as the narrowing of the spinal canal resulting from degenerative changes in the spinal joints, intervertebral discs, and the ligamentum flavum....

Sponsor: Marmara UniversityEnrolling: 1001 location
RECRUITINGPhase 2NCT03304821

Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease

Peripheral artery disease (PAD) is a disease in which plaque builds up in the arteries that carry blood to the head, organs, and limbs. PAD usually occurs in the arteries in the...

Sponsor: Emory UniversityEnrolling: 1761 location
RECRUITINGNCT05780359

Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

A multicenter, randomized, controlled, superiority clinical trial to evaluate the efficacy and safety of drug-eluting peripheral arterial stent system(G-stream) in the treatment...

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.Enrolling: 2801 location
RECRUITINGNCT05971394

IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial

The goal of this prospective, multicentre, single arm clinical trial is to assess the safety and effectiveness of Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System...

Sponsor: Biotyx Medical (Shenzhen) Co., Ltd.Enrolling: 1001 location
RECRUITINGNCT06631378

Transverse Versus Longitudinal Groin Incision in Vascular Surgery

The purpose of the study is to examine whether incision type has an influence on the development of groin wound complications after operation in the groin in vascular surgery....

Sponsor: Kolding SygehusEnrolling: 2321 location
RECRUITINGNCT07427108

Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety

The study aims to compare the technical feasibility and safety of road mapping-guided versus ultrasound-guided retrograde arterial puncture in patients with (CLTI) as measured by:...

Sponsor: Sohag UniversityEnrolling: 321 location
RECRUITINGEarly Phase 1NCT06319339

Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease

Peripheral artery disease (PAD) is associated with elevated oxidative stress, and oxidative stress has been implicated as the cause of reduced endothelial reactivity in...

Sponsor: University of NebraskaEnrolling: 201 location
RECRUITINGNCT07097857

Assessment of Revascularization in Plantar Foot of Diabetic Patients Pre and Post Angioplasty Using Spatial Frequency...

To explore the usefulness of SFDI in the assessment of revascularization pre and post intervention

Sponsor: Singapore General HospitalEnrolling: 151 location

Showing 50 of 100 trials.Search all Peripheral Artery Disease trials

Frequently Asked Questions

There are currently 100 clinical trials for Peripheral Artery Disease, with 100 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Peripheral Artery Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 3 Phase 3 trials for Peripheral Artery Disease, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.